MSN Laboratories launches SEMABEST semaglutide in India after CDSCO approval
Product priced lower than innovator drug and introduced for type 2 diabetes treatment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Sun Pharma launches brand film with Royal Challengers Bengaluru
Campaign highlights association as principal sponsor and health partner during T20 season
Orbicular, Gland Pharma and Apotex secure US FDA approval for generic INFUVITE ADULT injectable
ANDA approval with CGT designation grants six-month exclusivity for parenteral nutrition product in the United States
Novo Nordisk announces partnership with OpenAI
Partnership applies AI to drug discovery and operations across Novo Nordisk and OpenAI programmes
Aragen launches ChemiSHE, India’s first women-led chemistry synthesis laboratory
Announces strategic diversity initiative to add 800 - 1,000 women employees across scientific and leadership roles over the next…
India Pharma 2026 highlights policy push, innovation driving sectoral growth
India is poised to lead the global pharma landscape with a focus on biosimilars and specialty medicines stressed J.P. Nadda, Union…
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical…
GlobalData highlights shift towards localised manufacturing, inventory security, and diversified supply networks to address rising…
Merck signs MoU with MAHE to expand healthcare R&D talent development in India
Catalyst training programme launched to link academic learning with industry requirements
The GLP-1 revolution
A new class of drugs is reshaping global health,but India’s generics wave could change who benefits. Dr Rajpushpa Labh,Consultant…
India brings together a rare and powerful combination of capabilities
Dr Kshitij Panse,Chief Operation Officer,GATINN by Servier,in an interaction with Kalyani Sharma, discusses the strategic…
Foundayo, Lilly’s new oral GLP-1 pill for weight loss, now available in US
Eli Lilly and Company announced that Foundayo (orforglipron) is now available to adults with obesity or overweight with…
OPPI collaborates with NIPER Rae Bareli to advance research excellence
The Organisation of Pharmaceutical Producers of India (OPPI) has announced a strategic collaboration with the National Institute…
Merck expands Bengaluru facility to boost global supply of filtration devices
Merck, a leading science and technology company, announced the expansion of its manufacturing facility in Peenya, Bengaluru. The…
Lupin receives ANDA approval for Dapagliflozin, Metformin Hydrochloride extended-release tablets in…
Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug…
Glenmark receives US FDA approval for Progesterone Vaginal Inserts, 100 mg
Glenmark Pharmaceuticals has received final approval from the United States Food & Drug Administration (US FDA) for…
Lupin receives US FDA approval for Dapagliflozin tablets
Approval confirms bioequivalence to Farxiga for approved indications
Inventia enters the U.S. market with FDA approved Dapagliflozin tablets
Approval grants eligibility for 180-day shared generic drug exclusivity
Biocon launches Bosaya and Aukelso in the United States
Denosumab biosimilars made available through specialty pharmacies and healthcare providers
Alembic Pharmaceuticals secures USFDA approval for Dapagliflozin Tablets ANDA
Approval grants eligibility for 180-day shared generic drug exclusivity
Lupin receives Great Place To Work certification across global operations
Recognition based on study covering subsidiaries and employee participation